Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-23

Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for human umbilical cord mesenchymal stem cells in chronic kidney disease (stages 3-4) spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cell (mesenchymal stem cell)

Snippet

Sponsor: Tongji Hospital | Conditions: Chronic Kidney Diseases | Phase 1, Phase 2 | Status: UNKNOWN